News
20h
Axios on MSNWhy GLP-1s could become the "everything drug"
The biggest buzz around GLP-1 drugs these days has nothing to do with weight loss. And that might lead to some problems for ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Older Americans worried about cognitive decline can stay sharper for longer by exercising both their bodies and their brains ...
Lifestyle interventions can slow cognitive decline in your 60s and 70s, according to a large randomized controlled trial.
A cancer drug that has already been approved by the US Food and Drug Administration (FDA) could also help people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results